2 Intangible assets
The carrying amount of intangible assets comprises goodwill on the acquisition of the Erber Group in 2020 (€423 million), Pentapharm in 2007 (€34 million) and Crina in 2006 (€9 million). For full information on these assets including the discussion of the related impairment tests, see Note 8 Intangible assets to the ‘Consolidated financial statements’.
|
|
Total |
|---|---|---|
|
|
|
Balance at 1 January 2021 |
|
|
Cost |
|
825 |
Carrying amount |
|
825 |
|
|
|
Changes in carrying amount: |
|
|
- Exchange rate difference |
|
2 |
- Disposal subsidiaries |
|
(358) |
- Impairment |
|
(5) |
|
|
|
Balance at 31 December 2021 |
|
|
Cost |
|
469 |
Amortization and impairment losses |
|
5 |
Carrying amount |
|
464 |
|
|
|
Changes in carrying amount: |
|
|
- Exchange rate difference |
|
2 |
|
|
|
Balance at 31 December 2022 |
|
|
Cost |
|
471 |
Amortization and impairment losses |
|
5 |
Carrying amount |
|
466 |
